Literature DB >> 8438787

Investigation of bone marrow lymphocyte subsets in normal, reactive, and neoplastic states using paraffin-embedded biopsy specimens.

H P Horny1, M Wehrmann, H Griesser, M Tiemann, B Bültmann, E Kaiserling.   

Abstract

Bone marrow lymphocyte subsets in normal and reactive states and in neoplastic diseases involving the marrow were investigated with a select panel of monoclonal antibodies reactive on routinely processed, paraffin-embedded trephine biopsy material. In all cases, the antibodies beta F1 and UCHL1 (CD45RO) stained virtually equal numbers of T cells (reactive and neoplastic), whereas antibody OPD4 stained only about one half of this number of T cells. Antibody L26 (CD20) stained B cells (reactive and neoplastic) in all specimens. The T-cell to B-cell ratio in the normal marrow was between 4:1 and 5:1, and a significant increase in T-cell numbers was observed in reactive and myelodysplastic states. A significant increase in B-cell numbers, however, was seen only in marrow infiltrated by B-cell lymphoma. Bone marrow exhibiting infiltrates of B-cell lymphoma, acute leukemia, or myeloproliferative disorders showed normal or decreased numbers of T cells. These findings show that antibodies UCHL1, beta F1, and L26 can be used to determine the numbers of B and T lymphocytes in paraffin-embedded, formalin-fixed bone marrow specimens and thus may help to distinguish reactive T lymphocytosis from B-cell lymphoma.

Entities:  

Mesh:

Year:  1993        PMID: 8438787     DOI: 10.1093/ajcp/99.2.142

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  5 in total

1.  A panel of antibodies for the immunostaining of Bouin's fixed bone marrow trephine biopsies.

Authors:  J L Gala; F Chenut; K B Hong; J Rodhain; P Camby; M Philippe; J M Scheiff
Journal:  J Clin Pathol       Date:  1997-06       Impact factor: 3.411

2.  A comparison of flow cytometry, bone marrow biopsy, and bone marrow aspirates in the detection of lymphoid infiltration in B cell disorders.

Authors:  S P Sah; E Matutes; A C Wotherspoon; R Morilla; D Catovsky
Journal:  J Clin Pathol       Date:  2003-02       Impact factor: 3.411

3.  Development of a Target cell-Biologics-Effector cell (TBE) complex-based cell killing model to characterize target cell depletion by T cell redirecting bispecific agents.

Authors:  Xiling Jiang; Xi Chen; Thomas J Carpenter; Jun Wang; Rebecca Zhou; Hugh M Davis; Donald L Heald; Weirong Wang
Journal:  MAbs       Date:  2018-08-21       Impact factor: 5.857

4.  Optimal panel of immunohistochemistry for the diagnosis of B-cell non-Hodgkin lymphoma using bone marrow biopsy: a tertiary care center study.

Authors:  Nisha Marwah; Manali Satiza; Niti Dalal; Sudhir Atri; Monika Gupta; Sunita Singh; Rajeev Sen
Journal:  Blood Res       Date:  2021-03-31

5.  Inverted CD4+/CD8+ T cell ratio in Boran (Bos indicus) cattle.

Authors:  Maurine C Makau; Jessica Powell; James Prendergast; Perle Latré de Laté; Liam J Morrison; Andressa Fisch; Peter Gathura; Phillip Kitala; Timothy Connelley; Philip Toye
Journal:  Vet Immunol Immunopathol       Date:  2020-10-06       Impact factor: 2.046

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.